Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Morphine 100mg modified-release capsules
0407020Q0AAEBEB
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 790 |
|
Levetiracetam 1g granules sachets sugar free
0408010A0AAAMAM
|
Levetiracetam | Levetiracetam | Central Nervous System | 789 |
|
Nicorette Icy White 2mg medicated chewing gum
0410020B0BBAWBA
|
Nicorette | Nicotine | Central Nervous System | 781 |
|
Opiodur 100micrograms/hour transdermal patches (Zentiva)
0407020A0BRAPAH
|
Opiodur | Fentanyl | Central Nervous System | 778 |
|
Stanek 200mg/50mg/200mg tablets
0409010X0BDABAD
|
Stanek | Levodopa/carbidopa/entacapone | Central Nervous System | 778 |
|
DHC Continus 90mg tablets
0407020G0BBABAE
|
DHC Continus | Dihydrocodeine tartrate | Central Nervous System | 771 |
|
Actimorph 10mg orodispersible tablets
0407020Q0BQABGF
|
Actimorph | Morphine sulfate | Central Nervous System | 766 |
|
Sertraline 50mg/5ml oral suspension sugar free
0403030Q0AABDBD
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 761 |
|
Stalevo 50mg/12.5mg/200mg tablets
0409010X0BBAAAA
|
Stalevo | Levodopa/carbidopa/entacapone | Central Nervous System | 761 |
|
OxyNorm 10mg/ml concentrate oral solution
0407020ADBBABAB
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 760 |
|
Epanutin 30mg/5ml oral suspension
0408010Z0BBAAAA
|
Epanutin (Suspension/Tablet) | Phenytoin | Central Nervous System | 757 |
|
Trileptal 150mg tablets
0408010D0BBABAC
|
Trileptal | Oxcarbazepine | Central Nervous System | 755 |
|
Paliperidone 75mg/0.75ml prolonged-release inj pf syringes
0402020ABAAABAB
|
Paliperidone (Injection) | Paliperidone | Central Nervous System | 754 |
|
Champix 0.5mg/1mg 4 week treatment initiation pack
0410020C0BBADAC
|
Champix | Varenicline tartrate | Central Nervous System | 744 |
|
Ondansetron 4mg/2ml solution for injection ampoules
0406000S0AAAAAA
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 744 |
|
Ropinirole 3mg modified-release tablets
0409010H0AAARAR
|
Ropinirole hydrochloride | Ropinirole hydrochloride | Central Nervous System | 742 |
|
Affenid XL 18mg tablets
0404000M0BMAAAM
|
Affenid | Methylphenidate hydrochloride | Central Nervous System | 741 |
|
Paracetamol 1g tablets
0407010H0AADLDL
|
Paracetamol | Paracetamol | Central Nervous System | 736 |
|
Prothiaden 75mg tablets
0403010J0BBABAI
|
Prothiaden | Dosulepin hydrochloride | Central Nervous System | 735 |
|
Affenid XL 27mg tablets
0404000M0BMABAT
|
Affenid | Methylphenidate hydrochloride | Central Nervous System | 734 |
|
Nicotinell TTS 10 patches
0410020B0BCAAAP
|
Nicotinell | Nicotine | Central Nervous System | 730 |
|
Tapentadol 25mg modified-release tablets
0407020AGAAAIAI
|
Tapentadol | Tapentadol | Central Nervous System | 728 |
|
Exelon 9.5mg/24hours transdermal patches
0411000E0BBAGAG
|
Exelon | Rivastigmine | Central Nervous System | 725 |
|
Levodopa 125mg / Carbidopa 31.25mg / Entacapone 200mg tab
0409010X0AAAFAF
|
Levodopa/carbidopa/entacapone | Levodopa/carbidopa/entacapone | Central Nervous System | 721 |
|
Olanzapine 10mg oral lyophilisates sugar free
040201060AAAFAF
|
Olanzapine | Olanzapine | Central Nervous System | 721 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.